Press release from Companies

Published: 2021-06-09 14:30:05

SyntheticMR AB: SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical Systems

SyntheticMR announced today that they have entered a development project together with Juntendo University Hospital, based in Tokyo, Japan, and Canon Medical Systems. The project will focus on joint development and evaluation of quantitative MR imaging solutions for clinical practice.

For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from a single 6-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI MSK provides multiple contrast images and quantitative data for MSK anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI MSK is CE-marked and FDA 510(k) pending. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden. For more information, visit www.syntheticmr.com.

Läs mer hos Cision
Read more about SyntheticMR AB

Subscription